For National Epilepsy Awareness Month, Dr Nicola Davies shines a light on a rare form of epilepsy – Lennox-Gastaut syndrome (LGS).
LGS is a severe and rare form of childhood-onset epilepsy, typically presenting in children aged 3-5 years. The condition is slightly more common in males than females and can persist into adulthood. While the long-term prognosis of the disease varies, complete seizure control and normal development is rare.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze